Australia is gain access to innovative treatment for excess weight: Retatrutide. This dual molecule – working on both GLP-1 and GIP receptors – shows promising efficacy in global studies, suggesting considerable decreases in weight. While regulatory clearance remains with Australian regulators, a number of individuals dealing with weight-relate